Chronic HMG-CoA Reductase Inhibitor Treatment Contributes to Dysglycemia by Up-Regulating Hepatic Gluconeogenesis through Autophagy Induction

被引：0
|
作者：
Wang, Hye Jin
Park, Jae Yeo
Choe, Eun Yeong
Kwon, Obin
Lee, Yong-Ho
Kim, Gyuri
Bae, Jaehyun
Park, Se Hee
Yun, Yu Jung
Yun, Mijin
Kim, Chul Hoon
Lee, Hyangkyu
Kim, Young Bum
Kang, Eun Seok
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1787-P
引用
收藏
页码：A461 / A461
页数：1
相关论文
共 50 条
  • [31] HEPATIC HMG-COA REDUCTASE-ACTIVITY IN MAN - EFFECTS OF TREATMENT WITH BILE-ACIDS AND WITH CLOFIBRATE
    ANGELIN, B
    AHLBERG, J
    EINARSSON, K
    EWERTH, S
    LEIJD, B
    CIRCULATION, 1979, 60 (04) : 31 - 31
  • [32] COMPARATIVE-EVALUATION OF THE SAFETY AND EFFICACY OF HMG-COA REDUCTASE INHIBITOR MONOTHERAPY IN THE TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA
    HSU, I
    SPINLER, SA
    JOHNSON, NE
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (7-8) : 743 - 759
  • [33] A QUARTER CENTURY OF DRUG-TREATMENT OF DYSLIPOPROTEINEMIA, WITH A FOCUS ON THE NEW HMG-COA REDUCTASE INHIBITOR FLUVASTATIN
    LEVY, RI
    TROENDLE, AJ
    FATTU, JM
    CIRCULATION, 1993, 87 (04) : 45 - 53
  • [34] Combined treatment with LDL-apheresis, chenodeoxycholic acid and HMG-CoA reductase inhibitor for cerebrotendinous xanthomatosis
    Ito, S
    Kuwabara, S
    Sakakibara, R
    Oki, T
    Arai, H
    Oda, S
    Hattori, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 216 (01) : 179 - 182
  • [35] The use of ''add-on'' treatment in HMG-COA reductase inhibitor therapy to achieve target lipid levels
    Smith, DG
    BakkerArkmema, RG
    McLain, RW
    Black, DM
    AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 (10): : LC9 - LC9
  • [36] SHORT-TERM REGULATION OF HEPATIC CHOLESTEROL-SYNTHESIS THROUGH PHOSPHORYLATION OF HMG-COA REDUCTASE INVIVO
    STANGE, EF
    DIETSCHY, JM
    JOURNAL OF LIPID RESEARCH, 1983, 24 (10) : 1413 - 1414
  • [37] Apple phlorizin reduce plasma cholesterol by down-regulating hepatic HMG-CoA reductase and enhancing the excretion of fecal sterols
    Wang, Hao
    Sun, Zhen-ou
    Ur-Rehman, Rizwan
    Riaz, Sania
    Shen, Ting-Ting
    Fan, Zhen-Chuan
    Liu, Dong
    JOURNAL OF FUNCTIONAL FOODS, 2019, 62
  • [38] Variations in costs among payers in treatment with HMG-COA reductase inhibitor therapy to achieve target lipid levels
    Smith, DG
    BakkerArkema, RG
    McLain, RW
    Black, DM
    AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 (10): : LC10 - LC10
  • [39] GONADAL AND ADRENAL-FUNCTION DURING LONG-TERM TREATMENT WITH A NEW HMG-COA REDUCTASE INHIBITOR
    DOBS, AS
    SCHTEINGART, D
    CLINICAL RESEARCH, 1989, 37 (03): : A848 - A848
  • [40] The Effects of Combined Treatment with an HMG-CoA Reductase Inhibitor and PPARγ Agonist on the Activation of Rat Pancreatic Stellate Cells
    Lee, Beom Jae
    Lee, Hong Sik
    Kim, Chang Duck
    Jung, Sung Woo
    Seo, Yeon Seok
    Kim, Yong Sik
    Jeen, Yoon Tae
    Chun, Hoon Jai
    Um, Soon Ho
    Lee, Sang Woo
    Choi, Jai Hyun
    Ryu, Ho Sang
    GUT AND LIVER, 2012, 6 (02) : 262 - 269
12345